Publicaciones en colaboración con investigadores/as de Royal Melbourne Hospital (19)

2023

  1. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

    International Journal of Epidemiology, Vol. 52, Núm. 2, pp. 355-376

2020

  1. Newborn Screening for Presymptomatic Diagnosis of Complement and Phagocyte Deficiencies

    Frontiers in Immunology, Vol. 11

2019

  1. Combined PIK3CA and FGFR inhibition with alpelisib and infigratinib in patients with PIK3CA-mutant solid tumors, with or without fgfr alterations

    JCO Precision Oncology

  2. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

    npj Breast Cancer, Vol. 5, Núm. 1

2016

  1. Estimated GFR and the Effect of Intensive Blood Pressure Lowering after Acute Intracerebral Hemorrhage

    American Journal of Kidney Diseases, Vol. 68, Núm. 1, pp. 94-102

2015

  1. Impact of early valve surgery on outcome of staphylococcus aureus prosthetic valve infective endocarditis: Analysis in the international collaboration of endocarditis-prospective cohort study

    Clinical Infectious Diseases, Vol. 60, Núm. 5, pp. 741-749

  2. Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS

    PLoS ONE, Vol. 10, Núm. 6

  3. One-year outcome following biological or mechanical valve replacement for infective endocarditis

    International Journal of Cardiology, Vol. 178, pp. 117-123

  4. Randomized trial of TAS-102 for refractory metastatic colorectal cancer

    New England Journal of Medicine, Vol. 372, Núm. 20, pp. 1909-1919

2014

  1. Risk of relapse phenotype recurrence in multiple sclerosis

    Multiple Sclerosis Journal, Vol. 20, Núm. 11, pp. 1511-1522

2013

  1. HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort

    PLoS ONE, Vol. 8, Núm. 5

  2. Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke

    Clinical Infectious Diseases, Vol. 56, Núm. 2, pp. 209-217

2012

  1. Closing the case of APOE in multiple sclerosis: No association with disease risk in over 29 000 subjects

    Journal of Medical Genetics, Vol. 49, Núm. 9, pp. 558-562

2010

  1. Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study

    Leukemia Research, Vol. 34, Núm. 9, pp. 1143-1150

  2. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): A randomised factorial trial

    The Lancet, Vol. 376, Núm. 9748, pp. 1233-1243

2009

  1. Safety and immunogenicity of a new formulation of interferon β-1a (Rebif® New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results

    Multiple Sclerosis, Vol. 15, Núm. 2, pp. 219-228

  2. The expanded Global Registry of Acute Coronary Events: Baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes

    American Heart Journal, Vol. 158, Núm. 2, pp. 201.e5

2007

  1. Non-HACEK gram-negative bacillus endocarditis

    Annals of Internal Medicine, Vol. 147, Núm. 12, pp. 829-835

  2. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: An analysis from the ICE Prospective Cohort Study (ICE-PCS)

    American Heart Journal, Vol. 154, Núm. 6, pp. 1086-1094